Y-Intercept (HK)’s CDK Global, Inc. CDK Stock Holding History

Y-Intercept (HK)’s Portfolio CDK Stock Details CDK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,521	Closed	-$397K	–	1018
2021 Q4	$397K	Buy	+9,521	New	+$400K	0.09%	310
2021 Q1	–	Sell	-4,697	Closed	-$242K	–	880
2020 Q4	$242K	Buy	+4,697	New	+$223K	0.1%	388

Other funds holding CDK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

CCP

Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Y-Intercept (HK)'s CDK Position: Q1 2022 in Review

Y-Intercept (HK) sold out of CDK Global, Inc. (CDK) in Q1 2022, closing a stake of 9,521 shares — an estimated $397K sold.

Y-Intercept (HK) first reported a position in CDK in Q4 2020 and held it in 2 quarters. The position peaked at $397K in Q4 2021. 466 funds tracked by Wall St. Rank hold CDK as of Q1 2022.

Y-Intercept (HK) reported no remaining CDK Global, Inc. position as of Q1 2022 after selling out during the quarter.
Y-Intercept (HK) sold 9,521 CDK Global, Inc. shares in Q1 2022, an estimated $397K.
Y-Intercept (HK) first reported a position in CDK Global, Inc. in Q4 2020 and held it in 2 quarters.
Y-Intercept (HK)'s CDK Global, Inc. position peaked at $397K in Q4 2021.
466 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q1 2022.

Based on Y-Intercept (HK)'s 13F filing for Q1 2022, filed 16 May 2022.